Archive for December, 2009

12/22/09 ~ Endocrinologist Dr. Tony Deluzio from Novo Nordisk Pharmaceutical

Diabetes Living Today® radio program, provides listeners with education, inspiration and motivation to live healthy and well with diabetes.  Whether you have diabetes or know someone whoo does Diabetes Living Today® radio program offers experience, insight, education and tips to manage life with diabetes.  Through interviews, including “World Class” Research Scicntist, physicians and people living with diabetes, living well tips and questions from the listening audience, host Kitty Castellini and Endocrinologist Dr. Joseph J. Fallon, Jr. are there every step of the way to offer guidance, advice and most of all, support.

This week Kitty and Dr. Fallon will interview Dr. Tony Deluzio, Endocrinologist  from Novo Nordisk Pharmaceutical Listener’s are invited to call in with their questions and comments.  Tuesday Evening 8:00 pm ~ 9:00 pm (EST) on Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com  Call IN:  856-696-0092.

Dr. Tony Deluzio


Born in 1966 in Tripoli Libya, Dr Deluzio Currently resides in Bordentown, N.J. with his three daughters (Emily age 12, Ava & Amelia 3 yr old twins) and wife Rita.

Dr Deluzio received his B.S. at the University of Pennsylvania where he played varsity football for four years and was a member of three Ivy League championship football teams.

Dr Deluzio received his medical degree from the University of Health Sciences in Kansas City in 1995 where he graduated Summa Cum Laude.  Dr Deluzio did his residencies in Internal Medicine and Clinical Pathology at Hahnemann University Hospital in Philadelphia Pa..

After Residency, Dr Deluzio completed a combined Endocrinology and Research Fellowship at Temple University Hospital. During Fellowship his research interests involved Free Fatty Acids and their relationship with Insulin Resistance.

After Fellowship, Dr. Deluzio opened a solo Endocrinology Office in Shelby, N.C.   He also was the Director of a large Diabetes Center overseeing up to seven CDEs at one time.  During his time in clinical practice, Dr Deluzio was on multiple National Speaker Panels and continues to participate in Type 2 Diabetes Clinical Trials.

In 2006 Dr Deluzio Joined Novo Nordisk Pharmaceutical Company in Princeton N.J.  From 2006 -2008 Dr Deluzio held the position of Medical Scientific Director with his primary focus being on Interactions with other Endocrinologists to help improve patient outcomes in regards to their Diabetes.

Currently, Dr Deluzio is the Clinical Director at Novo Nordisk for NovoLog Mix 70/30 and all medical Devices.  This role includes the direction of all Novo Nordisk sponsored clinical trials and Publications that pertain to his assigned therapeutic areas.  In His current role at Novo Nordisk Dr Deluzio frequently lectures on the treatment of type 2 Diabetes both in the U.S. and Internationally.  His work on medical devices is focused on Injection Devices and Insulin Pumps.

Photo Above:  Dr. Tony Deluzio


AMERICAN WARRIOR SEVERELY INJURED IN AFGHANISTAN RECEIVES HISTORIC ISLET CELL TRANSPLANT


Diabetes Research Institute aids in life-saving procedure on Thanksgiving

(December 15, 2009)  A 21-year-old airman severely injured while serving his country in a remote area of Afghanistan is recovering at Walter Reed Army Medical Center (WRAMC) in Washington, D.C. after several surgeries and an unprecedented transplant. The extraordinary care is an example of military and civilian medical experts working together in the first known case of a successful isolation and transplantation of insulin-producing cells following a severe trauma requiring complete removal of the pancreas.  Camillo Ricordi M.D. and his team at the Diabetes Research Institute played a major role in the life-saving effort.

The airman was struck by three high velocity bullets on November 21 and was operated on twice by surgeons in forward combat medical bases in Salerno and Bagram, both in Afghanistan.  The surgeries included a rare but life-saving trauma Whipple, in which the head of the pancreas, a portion of the stomach, gallbladder, and entire duodenum were removed.  In addition, a portion of the airman’s large and small bowels were also removed.

A procedure to prevent infection was later performed at a military base in Germany, before the wounded warrior was transferred by the Air Force Critical Care Air Transport teams to Walter Reed four days after the initial injury.

The airman was taken back to the operating room at Walter Reed by Dr. Craig Shriver, chief of general surgery, to have his entire intra-abdominal structure reconstructed. During this operation, what was remaining of the airman’s pancreas was found to be damaged beyond repair from the gunshot wounds. “The optimal procedure at this point was to remove his entire remaining pancreas to prevent further leakage of the pancreatic enzymes and control the bleeding, which could be fatal,” said Dr. Shriver. “We knew that the procedure would lead to the most severe and life-threatening form of diabetes, which tends to be very brittle and difficult to control in this type of situation.”

At this point in the operation, Dr. Shriver sought the opinion of Dr Rahul Jindal, a transplant surgeon at Walter Reed and a clinical professor of surgery at George Washington University in Washington, D.C.  Dr. Jindal had training and experience in islet cell transplantation, which is considered the best hope for curing diabetes.

In islet cell transplantation, the insulin-producing islets are isolated from a donor pancreas and then reinfused in a patient’s liver where they later begin to produce insulin.

“Isolation and purification of pancreatic islets is a very intricate procedure which requires a specialized laboratory, and there are only a few such facilities in the United States,” said Dr. Jindal.  “I knew the Diabetes Research Institute at the University of Miami Miller School of Medicine had such a facility and I put a call in to its director, Dr. Camillo Ricordi, for his assistance in isolating the islets from our airman’s removed pancreas.”

Dr. Ricordi, scientific director at the Diabetes Research Institute, developed the method for isolating the islet cells from the pancreas and is considered a pioneer in the field. He immediately agreed to help, in his words, “anything to help a wounded warrior.”

Dr. Shriver proceeded to remove the remaining portion of the pancreas; and Drs. Jindal and Eric Elster, a Navy transplant surgeon, flushed the harvested pancreas and intact spleen with a special preservation solution, packed it in ice and transported it by courier to Miami.

“The organ arrived at 11 o’clock the night before Thanksgiving, and my cell processing team at the Diabetes Research Institute spent the next six hours performing the islet isolation and purification procedure,” explains Dr. Ricordi.  “More than 220,000 purified islets were then suspended in a specialized cold solution and flown back to Walter Reed.”

Late in the afternoon on Thanksgiving Day, the cells were successfully injected into the patient’s portal vein into his liver with Dr. Ricordi and his team coordinating the procedure via an internet connection with surgeons at Walter Reed.

Less than one week after surgery, there was clear evidence of pancreas islet function in the wounded warrior’s liver, as shown by the presence of a specialized blood test called c-peptide. Fifteen days after the procedure, that same blood test indicated the transplanted islet cells were functioning in the normal range. As time goes on, the pancreatic islets in the liver will take up new blood supply and the patient’s requirement of exogenous insulin is expected to further decrease, facilitating diabetes management and preventing the onset of complications of the disease, and improving his overall quality of life.

Teamwork and close coordination between the many professionals in the entire Military Trauma System at Walter Reed and at the Diabetes Research Institute at the University of Miami made this possible. This procedure may allow for more cases of islet transplantation following traumatic injury to the pancreas, where purification and transplantation of the insulin producing cells from even a segment of the rescued organ could prevent the development of severe diabetes and its complications.

December 15, 2009 ~ Dr. Eric Orth, Endocrinologist

Diabetes Living Today® radio program, provides listeners with education, inspiration and motivation to live healthy and well with diabetes. Whether you have diabetes or know someone who does Diabetes Living Today® radio program offers experience, insight, education and tips to manage life with diabetes. Through interviews, including “World Class” Research Scientist, physicians and people living with diabetes, living well tips and questions from the listening audience, host Kitty Castellini and Endocrinologist Dr. Joseph J. Fallon, Jr. are there every step of the way to offer guidance, advice, and most of all, support.

This week Kitty and Dr. Fallon will Interview Dr. Eric Orth, Endocrinologist from Internal Medicine Associates, Bloomington, IN.  Listener’s are invited to call in with their questions and comments.  Tuesday Evening 8:00 pm ~ 9:00 pm (EST) Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com  Call In:  856-696-0092.

Dr. Eric Orth

Dr. Eric Orth grew up in Oklahoma and went to college at Oklahoma State University.  He obtained his bachelors of science in physics in 1995 and my doctor of osteopathic medicine in 2000.  Dr. Orth completed his residency at the University of Illinois in 2003 and completed an additional year as chief resident of internal medicine. Dr. Orth finished his fellowship in diabetes, metabolism and endocrinology in 2006 at the University of Missouri.

Dr. Orth enjoys general endocrinology and has varied interests, including lipid disorders, bone metabolism disorders as well as performing thyroid US and FNA.  He completed certification for clinical densitometry and clinical hypertension.  Dr. Orth has been recognized by the NCQA for excellence in diabetes care.

He is currently practicing clinical endocrinology at Internal Medicine Associates, a multispecialty group in Bloomington Indiana, and has been working at IMA since graduation from fellowship in 2006.  Additionally, Dr. Orth performs lectures for the second year medical student students at Indiana University in Bloomington, as an assistant clinical professor of medicine.

Photo Above:  Dr. Eric Orth



12/08/09 ~ “Racing to Cure Diabetes with Team Type 1 and Team Type 2″

Diabetes Living Today® radio program, provides listeners with education, inspiration and motivation to live healthy and well with diabetes.  Whether you have diabetes or know someone whoo does Diabetes Living Today® radio program offers experience, insight, education and tips to manage life with diabetes.  Through interviews, including “World Class” Research Scicntist, physicians and people living with diabetes, living well tips and questions from the listening audience, host Kitty Castellini and Endocrinologist Dr. Joseph J. Fallon, Jr. are there every step of the way to offer guidance, advice and most of all, support.

This week Kitty and Dr. Fallon will interview Joe Eldridge from Team Type 1 and Peter Cowley from Team Type 2.  Listener’s are invited to call in with their questions and comments.  Tuesday Evening 8:00 pm ~ 9:00 pm (EST) on Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com  Call IN:  856-696-0092.

“Winners of the eight-person team division of the Race Across America.”

Joe Eldridge

Joe Eldridge’s passion for cycling, shared with fellow collegiate cyclist Phil Southerland (who also has diabetes), led to the creation of Team Type 1 in 2004.  Two years later, Team Type 1 won the first of two corporate team division titles in the Race Across America (RAAM), and in 2008, their inaugural pro season, Team Type 1 compiled 45 victories and placed two riders in the Olympics.  Now their mission is growing even larger.

“Team Type 1 is a support system,” Eldridge said.  “Every day we inspire each other to test more often, to make adjustments in our routine to be that much better. ”

Eldridge was diagnosed with Type 1 diabetes at age 10.  But that didn’t stop him from becoming a competitive cyclist (after stints in soccer, football, and triathlons).  Not being a terrific swimmer or runner led him to take up track cycling at Auburn University, where he and Southerland - who raced against him in college - laid the groundwork for Team Type 1.

With their sights set on simply finishing RAAM in 2006, they surprised themselves with a victory.  A year later, they won the eight-person corporate team title again - in record time.  Now Eldridge looks forward to achieving the same success in his third professional season.  In 2009, he won more than 20 races on the track, including “Rider of the Year” honors at the Dick Lane Velodrome in East Point, Ga.

“We have a strong group of riders, experienced management, great sponsors, and an important message,” he said.  “Everything is in place for us to have another great year, both on and off the bike.”

Photo courtesy of Marco Quezada PhotographyJoe Eldridge Team Type 1

Peter Cowley

There could not be a more perfect candidate for the Team Type 2 cycling team than Peter Cowley.

Already an avid cyclist who has seen several editions of the Tour de France in person, the Milwaukee, and Wisconsin resident is also an associate director at the local American Diabetes Association chapter.  He annually organizes the popular Tour de Cure fund-raising ride, of which so many Team Type 1 and Team Type 2 riders participate in around the nation.

He arrived at the team’s January training camp in Santa Barbara, California, tipping the scales more than 325 pounds.  But through practice of a balanced diet and daily exercise that involved pedaling as much as he could when he wasn’t working, Cowley shed more than 25 pounds over the next six months.

His battle to overcome Type 2 diabetes has not been the only one he has been fighting.  A pair of herniated discs in his back (a condition that leads to irritation of spinal nerves and can cause back and leg pain) made cycling painful at times.  But the 42-year-old says he is ready to go.

“I want to be a spokesman for cycling as a lifestyle choice for people with diabetes,” he said.  “I was flattered to be asked to be a part of the team.  I get so much satisfaction speaking that special language to others that have diabetes.”

Photo courtesy of Marco Quezada Photography: Peter Cowley Team Type 2

“Team Type1 and Team Type2 are sponsored by Lantus (www.lantus.com) and Apidra (www.apidra.com), manufactured by sanofi-aventis.”